PHARMACEUTICAL COMPOSITION COMPRISING AN ANGIOTENSIN II-RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER FOR THE TREATMENT OF ARTERIAL HYPERTENSION

The invention concerns a pharmaceutical composition in tablet-tablet form having at least two phases and comprising an inner tablet which has zero order kinetics for at least one calcium channel blocking agent and an outer tablet which has zero order kinetics and/or order one kinetics without a dela...

Full description

Saved in:
Bibliographic Details
Main Authors VÁZQUEZ FLORES, CONCEPCIÓN ALBINA, GALO MOJICA, LAURA IVONNE, MARCELÍN JIMÉNEZ, GABRIEL, GARCIA PÉREZ, MIGUEL ÁNGEL, ANGELES MORENO, ALIONKA CITLALLI P, CARO RODRÍGUEZ, OCTAVIO
Format Patent
LanguageEnglish
French
Spanish
Published 07.08.2014
Online AccessGet full text

Cover

Loading…
Abstract The invention concerns a pharmaceutical composition in tablet-tablet form having at least two phases and comprising an inner tablet which has zero order kinetics for at least one calcium channel blocking agent and an outer tablet which has zero order kinetics and/or order one kinetics without a delay time for at least one angiotensin II-receptor antagonist. The composition can be used for the treatment of arterial hypertension, congestive cardiac insufficiency, unstable angina pectoris, acute myocardial infarction, diabetic nephropathy or associated disorders. La presente invención se refiere a una composición farmacéutica en forma de tableta-tableta de al menos dos fases que comprende una tableta interna que presenta una cinética de orden cero de al menos un agente bloqueador de los canales de calcio; y, una tableta externa que presenta una cinética de orden cero y/o de orden uno sin tiempo de retardo de al menos un agente antagonista de los receptores de la angiotesina II. Dicha composición es útil para el tratamiento de hipertensión arterial, insuficiencia cardiaca congestiva, angina de pecho inestable, infarto agudo del miocardio, nefropatía diabética o desórdenes asociados. La présente invention concerne une composition pharmaceutique sous forme de pastille-pastille d'au moins deux phases qui comprend une pastille interne qui présente une cinétique d'ordre zéro d'au moins un agent bloqueur des canaux calciques; et, une pastille externe qui présente une cinétique d'ordre zéro et/ou d'ordre un sans temps de retard d'au moins un agent antagoniste des récepteurs de l'angiotensine II. Ladite composition est utile pour le traitement de l'hypertension artérielle, de l'insuffisance cardiaque congestive, de l'angine de poitrine instable, de l'infarctus aigu du myocarde, de la néphropathie diabétique ou de troubles associés.
AbstractList The invention concerns a pharmaceutical composition in tablet-tablet form having at least two phases and comprising an inner tablet which has zero order kinetics for at least one calcium channel blocking agent and an outer tablet which has zero order kinetics and/or order one kinetics without a delay time for at least one angiotensin II-receptor antagonist. The composition can be used for the treatment of arterial hypertension, congestive cardiac insufficiency, unstable angina pectoris, acute myocardial infarction, diabetic nephropathy or associated disorders. La presente invención se refiere a una composición farmacéutica en forma de tableta-tableta de al menos dos fases que comprende una tableta interna que presenta una cinética de orden cero de al menos un agente bloqueador de los canales de calcio; y, una tableta externa que presenta una cinética de orden cero y/o de orden uno sin tiempo de retardo de al menos un agente antagonista de los receptores de la angiotesina II. Dicha composición es útil para el tratamiento de hipertensión arterial, insuficiencia cardiaca congestiva, angina de pecho inestable, infarto agudo del miocardio, nefropatía diabética o desórdenes asociados. La présente invention concerne une composition pharmaceutique sous forme de pastille-pastille d'au moins deux phases qui comprend une pastille interne qui présente une cinétique d'ordre zéro d'au moins un agent bloqueur des canaux calciques; et, une pastille externe qui présente une cinétique d'ordre zéro et/ou d'ordre un sans temps de retard d'au moins un agent antagoniste des récepteurs de l'angiotensine II. Ladite composition est utile pour le traitement de l'hypertension artérielle, de l'insuffisance cardiaque congestive, de l'angine de poitrine instable, de l'infarctus aigu du myocarde, de la néphropathie diabétique ou de troubles associés.
Author GALO MOJICA, LAURA IVONNE
VÁZQUEZ FLORES, CONCEPCIÓN ALBINA
GARCIA PÉREZ, MIGUEL ÁNGEL
CARO RODRÍGUEZ, OCTAVIO
ANGELES MORENO, ALIONKA CITLALLI P
MARCELÍN JIMÉNEZ, GABRIEL
Author_xml – fullname: VÁZQUEZ FLORES, CONCEPCIÓN ALBINA
– fullname: GALO MOJICA, LAURA IVONNE
– fullname: MARCELÍN JIMÉNEZ, GABRIEL
– fullname: GARCIA PÉREZ, MIGUEL ÁNGEL
– fullname: ANGELES MORENO, ALIONKA CITLALLI P
– fullname: CARO RODRÍGUEZ, OCTAVIO
BookMark eNqNTctqwlAQzaJdaOs_DHQtNNaFWY7XSe7QZCZMRsSVSLmuJAr2U_rBXsQPKBw4Dw7nTIuX8TKmSfHXR7QOA22dA7YQtOt1YGeVhzYeWBpAyWhYnSR7YJ4bBepdLeeOjQoPnuUGEPJM4G0HIaIItbBuNXyTQZ3LHgncCL0jcdAa0JyM83Hc92SPeZX34vV0PN_S7MlvxUdNHuI8XS-HdLsef9KYfg87XXyWy7KsqlWFi6__te5FxUS4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSITION PHARMACEUTIQUE PRÉSENTANT UN ANTAGONISTE DES RÉCEPTEURS DE L'ANGIOTENSINE II ET UN BLOQUEUR DES CANAUX CALCIQUES POUR LE TRAITEMENT DE L'HYPERTENSION ARTÉRIELLE
COMPOSICIÓN FARMACÉUTICA CON UN ANTAGONISTA DE LOS RECEPTORES DE LA ANGIOTESINA II Y UN BLOQUEADOR DE LOS CANALES DE CALCIO PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL
ExternalDocumentID WO2014119989A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2014119989A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:51 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2014119989A23
Notes Application Number: WO2014MX00034
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140807&DB=EPODOC&CC=WO&NR=2014119989A2
ParticipantIDs epo_espacenet_WO2014119989A2
PublicationCentury 2000
PublicationDate 20140807
PublicationDateYYYYMMDD 2014-08-07
PublicationDate_xml – month: 08
  year: 2014
  text: 20140807
  day: 07
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies GARCIA PÉREZ, MIGUEL ÁNGEL
RelatedCompanies_xml – name: GARCIA PÉREZ, MIGUEL ÁNGEL
Score 2.94563
Snippet The invention concerns a pharmaceutical composition in tablet-tablet form having at least two phases and comprising an inner tablet which has zero order...
SourceID epo
SourceType Open Access Repository
Title PHARMACEUTICAL COMPOSITION COMPRISING AN ANGIOTENSIN II-RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER FOR THE TREATMENT OF ARTERIAL HYPERTENSION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140807&DB=EPODOC&locale=&CC=WO&NR=2014119989A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8IGvVNUeMfNE00e1scMBh7IGZ0hVVZu4yi-EQY2xITA0Rm_CJ-YK8NKE8kfbi2yTVtc3f9tXdXhO5bSV5rgw4wnRyQjq0CQJKaNTWVrcos17LTVDvI8lYwsp_GzXEJfWxiYXSe0G-dHBEkagbyXmh9vfy_xPK1b-XqIXmHpsVjT3Z8Y42OAS20Lcfwux0aCV8QgxDAbQaPdV9NxZO5HijsPThIO0oe6EtXxaUst41K7xjtR8BvXpygUraqoEOy-Xutgg7C9ZM3kGvpW52inyjw4tAjdCRVFgNMRBiJIVOXTJqO2ZDxPvY4lD4TknKoY8bMmBIaSRFDu_T6grOhBNLHHgY2hI1CTAKPczrA3YEgzzTGgA2xDCiWMfWkyvePRQ_rsy-DgYO3iMaaveBn6K5HJQlMmN7kbzUnr2J7LRrnqDxfzLMLhKduWwMQO09Tu9XMkzyr27NGZrv1etqcppeouovT1e7ua3Skqtp3zqmicvH5ld2APS-SW70NvxIgmI4
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8IGvFNUeMf1CYa3hYHDAYPxIyuYxXWLqMoPhHGtsTEAJEZv4gf2GsD6hNJH6695JZ1ubv-rnc3hO5bcVZrgw0w7AyQjqUKQOKaOTOUr0rNjmkliU6Q5S1_bD1NmpMCet_Wwug-oV-6OSJo1Bz0Pdf2evUXxHJ1buX6IX6DpeWjJ7tudYOOAS20Tbvq9ro0FK4gVUIAt1V5pHk1VU_WccBg78Eh21b6QJ97qi5l9d-peEdoPwR5i_wYFdJ1GZXI9t9rZXQQbK68gdxo3_oEfYe-EwUOoWOpuhhgIoJQjJgKMmk6YiPG-9jhMPpMSMphjhkzIkpoKEUE69LpC85GEkgXOxjEEDYOMPEdzukQ94aCDGiEARti6VMsI-pI1e8fCw_rsy-DB_uvIY20eMFP0Z1HJfENeL3p725OX8T_vWicoeJiuUjPEZ512hqAWFmSWK1mFmdp3Zo3UqtTryfNWXKBKrskXe5m36KSL4PhdMj44AodKpbOo7MrqJh_fKbX4Nvz-EZ_kh9oNpuB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+COMPRISING+AN+ANGIOTENSIN+II-RECEPTOR+ANTAGONIST+AND+A+CALCIUM+CHANNEL+BLOCKER+FOR+THE+TREATMENT+OF+ARTERIAL+HYPERTENSION&rft.inventor=V%C3%81ZQUEZ+FLORES%2C+CONCEPCI%C3%93N+ALBINA&rft.inventor=GALO+MOJICA%2C+LAURA+IVONNE&rft.inventor=MARCEL%C3%8DN+JIM%C3%89NEZ%2C+GABRIEL&rft.inventor=GARCIA+P%C3%89REZ%2C+MIGUEL+%C3%81NGEL&rft.inventor=ANGELES+MORENO%2C+ALIONKA+CITLALLI+P&rft.inventor=CARO+RODR%C3%8DGUEZ%2C+OCTAVIO&rft.date=2014-08-07&rft.externalDBID=A2&rft.externalDocID=WO2014119989A2